Earnings Call Summary | NeueHealth(NEUE.US) Q1 2024 Earnings Conference
Earnings Call Summary | NeueHealth(NEUE.US) Q1 2024 Earnings Conference
The following is a summary of the NeueHealth, Inc. (NEUE) Q1 2024 Earnings Call Transcript:
以下是NeueHealth, Inc.（NEUE）2024年第一季度業績電話會議記錄摘要：
Financial Performance:
財務業績：
NeueHealth reported a consolidated Q1 revenue of $245.1 million, slightly below expectations due to lower NeueCare volume and ACO business development.
The company delivered a gross margin of $48.2 million and a quarterly adjusted EBITDA of $2.5 million.
NeueCare segment revenue was $73.6 million with an operating income of $9.8 million.
The NeueSolution segment posted revenue of $173.9 million and an operating loss of $2.9 million.
NeueHealth報告稱，由於NeueCare銷量下降和ACO業務發展，第一季度合併收入爲2.451億美元，略低於預期。
該公司的毛利率爲4,820萬美元，季度調整後的息稅折舊攤銷前利潤爲250萬美元。
NeueCare板塊收入爲7,360萬美元，營業收入爲980萬美元。
NeueSolution板塊公佈的收入爲1.739億美元，營業虧損爲290萬美元。
Business Progress:
業務進展：
The NeueCare segment has expanded in Central Florida, adding 41,000 more consumers with plans for further expansions in 2024 and beyond.
NeueHealth served a total of 469,000 consumers across the NeueCare and NeueSolution segments in Q1 2024.
Growth in partnerships within the NeueSolution segment marks it as a key driver for the future.
The company serves approximately 40% of the 745,000 ACA marketplace consumers in the Miami-Dade market, receiving high customer satisfaction scores.
The company aims to serve between 475,000 and 500,000 consumers across both segments by the end of 2024, focusing on a value-driven, consumer-centric care model.
NeueCare細分市場已在佛羅里達州中部擴張，增加了41,000名消費者，並計劃在2024年及以後進一步擴張。
2024年第一季度，NeueHealth爲NeueCare和NeueSolution領域的共計46.9萬名消費者提供了服務。
NeueSolution細分市場內部合作伙伴關係的增長標誌着其成爲未來的關鍵驅動力。
該公司爲邁阿密戴德市場74.5萬名ACA市場消費者中的約40％提供服務，獲得了很高的客戶滿意度分數。
該公司的目標是到2024年底爲這兩個細分市場的47.5萬至50萬名消費者提供服務，重點是價值驅動、以消費者爲中心的護理模式。
Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示：欲了解更多詳情，請訪問投資者關係網站。本文僅供投資者參考，不構成任何投資建議。
譯文內容由第三人軟體翻譯。